Developer of breakthrough biotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections Ben Buelow, MD, PhD (Co-founder), Roland Buelow, PhD (Co-founder), Wim Van Schooten, PhD (Co-founder)
Developer of breakthrough biotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections Ben Buelow, MD, PhD (Co-founder), Roland Buelow, PhD (Co-founder), Wim Van Schooten, PhD (Co-founder)